Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Cancer Sci. 2010 Feb;101(2):306-12. doi: 10.1111/j.1349-7006.2009.01441.x. Epub 2009 Nov 16.
Transforming growth factor (TGF)-beta signaling has interesting characteristics in the context of cancer. Although perturbations of TGF-beta signaling are strongly implicated in cancer progression, TGF-beta signaling has both tumor-suppressive and tumor-promoting effects. For example, TGF-beta inhibits cancer cell proliferation in some cellular contexts, but promotes it in others. Although several approaches to treating cancer have been considered using TGF-beta-based therapeutic strategies, the contradictory behaviors of TGF-beta have made these approaches complex. To put them to practical use, either the tumor-suppressive or tumor-promoting arm needs to be specifically manipulated. However, there is virtually no method to specifically regulate a certain cell response induced by TGF-beta. In this review, we first consider the basic machinery of TGF-beta signaling, and describe several cell responses induced by TGF-beta stimulation in specific contexts. Mechanisms by which TGF-beta can induce several responses in a cellular context-dependent fashion are discussed with established paradigms and models. We also address perspectives on the specific control of only a subset of numerous cell responses induced by TGF-beta stimulation. Such methods will aid specific regulation of either the tumor-suppressive or tumor-promoting arm of the TGF-beta pathway and in realization of TGF-beta-based treatment of malignant tumors.
转化生长因子 (TGF)-β 信号在癌症背景下具有有趣的特征。尽管 TGF-β 信号的扰动强烈暗示了癌症的进展,但 TGF-β 信号既有肿瘤抑制作用,也有肿瘤促进作用。例如,TGF-β 在某些细胞环境中抑制癌细胞增殖,但在其他环境中促进其增殖。尽管已经考虑了几种使用 TGF-β 为基础的治疗策略来治疗癌症,但 TGF-β 的矛盾行为使得这些方法变得复杂。为了将它们付诸实际应用,需要专门操纵肿瘤抑制或肿瘤促进臂。然而,实际上几乎没有方法可以专门调节 TGF-β 诱导的特定细胞反应。在这篇综述中,我们首先考虑 TGF-β 信号的基本机制,并描述在特定环境下 TGF-β 刺激诱导的几种细胞反应。讨论了 TGF-β 如何以细胞环境依赖的方式诱导几种反应的机制,并使用已建立的范例和模型进行了讨论。我们还探讨了仅对 TGF-β 刺激诱导的众多细胞反应中的一部分进行特定控制的观点。这些方法将有助于 TGF-β 途径的肿瘤抑制或肿瘤促进臂的特异性调节,并实现 TGF-β 治疗恶性肿瘤的应用。